SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (13208)10/5/2004 5:49:06 PM
From: Sam Citron  Read Replies (2) of 52153
 
I wonder if anyone might share any comments on option valuation. CTIC March 10 Call (CUCCB) is currently trading at $1.30 while the stock is only $6.66. That seems to me to be an exceptionally handsome call premium for less than 6 month call on a stock that needs to climb 50% to come in the money.

I thought $1 was attractive price to sell these CCs, and now am amazed to see the price has risen further.

Any thoughts?

Sam
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News